Overview

The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)

Status:
Terminated
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The safety and efficacy of MK0724 will be assessed in patients with acute middle cerebral artery stroke using the Action Reach Arm Test (ARAT). This test allows measurement of a specific functional deficit and subsequent recovery correlating with the specific area of stroke in the brain.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.